期刊文献+

急性冠脉综合征患者血清C反应蛋白、血脂的变化及关系探讨 被引量:1

The relation between CRP and lipid in patients with acute coronary syndrome and its clinic value
下载PDF
导出
摘要 目的探讨C反应蛋白(CRP)及血脂在急性冠脉综合征(ACS)患者中的临床意义。方法通过比较54例急性冠脉综合征,28例稳定型心绞痛(SAP)及25例健康正常人的CRP及血脂变化,以及分析其相关性,从而了解二者在急性冠脉综合征发病中的作用。结果ACS组的CRP(12.3±7.60)mg/L、TG(1.56±0.87)mmol/L、HDL-C(1.32±0.45)mmol/L、LDL-C(3.72±1.35)mmol/L;SAP组的CRP(8.01±5.46)mmol/L、TG(1.52±0.78)mm01/L,HDL-C(1.35±0.51)mmol/L、LDL—C(2.34±1.02)mmol/L;对照组的CRP(7.86土5.52)mmol/L、TG(1.54±0.81)mmol/L、HDL-C(1.34±0.48)mmol/L、LDL—C(2.47±1.08)mmol/L。ACS组的CRP及LDL-C水平较SAP组及对照组明显升高(P均〈0.05),而3组间的TG及HDL—C水平比较无明显差异(P〉0.05)。各组的CRP分别与TG、HDL-C、LDL-C进行相关分析,均无直线相关性。结论血清CRP及LDL-C水平与ACS发病有关,可能是ACS发病及预后判断的独立观察指标。 Objective To investigate the clinic value of C-reactive protein(CRP)and lipid on patients wit acute coronary syndrome(ACS).Methods The serum levels of CRP and lipid were measured in all patients and healthy control group. Comparing the two parameters in different group and analyzing the correlation between CRP and lipid in same group. Results In ACS group, the serum level of CRP was (12.3±7.60)mg/L, TG was (1.56±0.87)mmol/L, HDL-C was (1.32± 0. 45)mmol/L, LDL-C was (3. 72 ± 1.35)mmol/L . In SAP group, the serum level of CRP was (8. 01 ± 5.46)mmol/L, TG was (1.52 ± 0. 78)mmol/L, HDL-C was (1.35 ± 0. 51)mmol/L, LDL-C was (2.34± 1. 02) mmol/L. In control group, the serum level of CRP was (7.86±5.52)mmol/L, TG was (1.54 ±0. 81)mmol/L. HDL-C was (1.34 ± 0. 48)mmol/L, LDL-C was (2.47 ± 1.08)mmol/L The serum levels of CRP and LDL-C were higher in ACS group than that in SAP group and in control group. There was not significantly difference between TG and HDL-C in three groups. There were not positive linear correlations between CRP and TG, HDL-C, LDL-C in all groups, respectively. Conclusion The serum levels of CRP and LDL-C are associated with the genesis of ACS, and are the indicator of diagnosis and prognosis for patients with ACS.
出处 《国际医药卫生导报》 2008年第21期19-21,共3页 International Medicine and Health Guidance News
关键词 急性冠脉综合征 C反应蛋白 血脂 Acute coronary syndrome C-reactive protein Lipid
  • 相关文献

参考文献4

  • 1刘坤申,戚国庆.急性冠状动脉综合征的诊治策略[J].河北医药,2002,24(5):356-357. 被引量:12
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction. A report of American collage of cardiology/American heart association task force on practice guidelines[J].J Am Coll Cardiol, 2000,36(3):970. 被引量:1
  • 3Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease, iHi and CDS Scientific Statement [J]. Circulation, 2003, 107: 499- 511. 被引量:1
  • 4Bickel C, Rupprecht HJ, Blankenberg S, et al. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographicalty proven coronary artery disease [J].Am J Cardiol, 2002,89:901-908. 被引量:1

二级参考文献2

共引文献11

同被引文献10

  • 1Almagor M, Keren A, Banai S. Increased C-reactive protein level after coronary stent implantation in patients withstable coronary artery disease. Am Heart J,2003,145 (2) :248-253. 被引量:1
  • 2Patti G, Pascefi V, Colonna G, et al. Atorvastatin pretreatment im-proves outcomes in patients with acute coronary syndromes under- going early percutaneous coronary intervention : results of the AR- MYDA-ACS randomized trim. J Am Coll Cardiol,2007,49( 12 ) : 1272-1276. 被引量:1
  • 3ACC/AHA Guidelines for the management of patients with unsta- ble angina and non-ST-segment elevation myocardial infarction. A report of American college cardiology/American heart association task force for partition guidelines. J Am Coil Cardiol, 2002,39 (6) :542-553. 被引量:1
  • 4Hong MK,Mintz GS,Lee CW,et al. Comparlison of coronary plaque rupture between stable angina and acute myocardial infarction: a three Yessel intravaseular ultrasound study in 235 patients. Circula- tion,2004,110(8) :928-933. 被引量:1
  • 5Franzoni F, Quin0nes-Galvan A, Regoli F, et al. A comparative study of the in vitro antioxidant activity of statins. Int J Cardiol, 2003,90(2-3 ) :31-33. 被引量:1
  • 6Briguori C, Viseonti G, Foeaeeio A, et al. Novel approaches for preventing or limiting events (Naples) II trim : impact of a single high loading dose of atorvastatin on peripmeedural myocardial in- farction. J Am Coll Cardio1,2009,54 (23) :2157-2162. 被引量:1
  • 7Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, pmvastatin, and the risk of coronary events after myocardial infarction in pa- tients with average cholesterol levels:Cholesterol and Recurrent Events( CARE ) Investigatom. Circulation, 1998,98 ( 9 ) : 839- 844. 被引量:1
  • 8黄湘,谭德安,谭家余,钟锋,李舟文.老年急性冠脉综合征患者E-选择素与氧化应激的相关性研究[J].实用预防医学,2009,16(3):683-686. 被引量:2
  • 9蔚珍.阿托伐他汀强化治疗急性冠脉综合征380例临床观察[J].临床医药实践,2009,18(10):757-758. 被引量:3
  • 10赵水平.冠心病整体防治中他汀类药物的重要地位[J].中华心血管病杂志,2004,32(4):379-381. 被引量:159

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部